Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I comparison of recombinant factor VIIa versus NovoSeven in fondaparinux-pretreated healthy men
NL-OMON34613Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Jan 2011
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of coagulation factor VIIa, AryoSeven and fondaparinux, sponsored by Centre for Human Drug Research. Started Jan 2011; status: active, not recruiting.
02
Drugs
coagulation factor VIIaAryoSevenfondaparinux
Beyond the preview
Go deeper on NL-OMON34613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34613.